218 related articles for article (PubMed ID: 37585250)
1. The Adverse Effects and Nonmedical Use of Methylphenidate Before and After the Outbreak of COVID-19: Machine Learning Analysis.
Shin H; Yuniar CT; Oh S; Purja S; Park S; Lee H; Kim E
J Med Internet Res; 2023 Aug; 25():e45146. PubMed ID: 37585250
[TBL] [Abstract][Full Text] [Related]
2. Twitter Analysis of the Nonmedical Use and Side Effects of Methylphenidate: Machine Learning Study.
Kim MG; Kim J; Kim SC; Jeong J
J Med Internet Res; 2020 Feb; 22(2):e16466. PubMed ID: 32130160
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
[TBL] [Abstract][Full Text] [Related]
5. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
6. Prediction of sleep side effects following methylphenidate treatment in ADHD youth.
Yoo JH; Sharma V; Kim JW; McMakin DL; Hong SB; Zalesky A; Kim BN; Ryan ND
Neuroimage Clin; 2020; 26():102030. PubMed ID: 31711956
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA
PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721
[TBL] [Abstract][Full Text] [Related]
8. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
9. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
11. Misuse of Methylphenidate.
Clemow DB
Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
Man KKC; Häge A; Banaschewski T; Inglis SK; Buitelaar J; Carucci S; Danckaerts M; Dittmann RW; Falissard B; Garas P; Hollis C; Konrad K; Kovshoff H; Liddle E; McCarthy S; Neubert A; Nagy P; Rosenthal E; Sonuga-Barke EJS; Zuddas A; Wong ICK; Coghill D;
Lancet Psychiatry; 2023 May; 10(5):323-333. PubMed ID: 36958362
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
15. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.
Winhusen TM; Lewis DF; Riggs PD; Davies RD; Adler LA; Sonne S; Somoza EC
J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):455-63. PubMed ID: 22040190
[TBL] [Abstract][Full Text] [Related]
16. Nonmedical Use of Stimulants Is Associated With Riskier Sexual Practices and Other Forms of Impulsivity.
Grant JE; Redden SA; Lust K; Chamberlain SR
J Addict Med; 2018; 12(6):474-480. PubMed ID: 30095567
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Osland ST; Steeves TD; Pringsheim T
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
[TBL] [Abstract][Full Text] [Related]
18. [Methylphenidate misuse].
Bruggisser M; Bodmer M; Liechti ME
Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
[TBL] [Abstract][Full Text] [Related]
19. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
20. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
